Ex Parte Venugopalan et alDownload PDFPatent Trial and Appeal BoardFeb 18, 201611262697 (P.T.A.B. Feb. 18, 2016) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 11/262,697 10/31/2005 27777 7590 02/22/2016 BERNARD F PLANTZ JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK, NJ 08933-7003 FIRST NAMED INVENTOR Ramakrishna Venugopalan UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. COD5114USNP 1077 EXAMINER SIRMONS, KEVIN C ART UNIT PAPER NUMBER 3763 NOTIFICATION DATE DELIVERY MODE 02/22/2016 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address( es): jnjuspatent@corus.jnj.com lhowd@its.jnj.com pairjnj@firsttofile.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte RAMAKRISHNA VENUGOP ALAN and GREG M. SCH OM Appeal2013-005974 Application 11/262,697 1 Technology Center 3700 Before MICHELLE R. OSINSKI, JAMES J. MAYBERRY, and MARK A. GEIER, Administrative Patent Judges. GEIER, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE This is a decision on appeal, under 35 U.S.C. § 134(a), from the Examiner's rejection of claims 1, 3-14, 16-20,2 22, and 23. 3 Br. 2. We 1 According to Appellants, the real party in interest is Codman & Shurtleff, Inc., a wholly-owned subsidiary of Johnson & Johnson. Br. 1. 2 We note that while both Appellants and the Examiner indicate that claim 15 has been rejected, (see Final Act. l; see also Br. 2), we do not identify a specific rejection of claim 15. 3 Appellants cancelled claims 2 and 21, and those claims are not before us in this Appeal. See Br. 2. Appeal2013-005974 Application 11/262,697 have jurisdiction under 35 U.S.C. § 6(b ). We AFFIRM and enter NEW GROUNDS OF REJECTION UNDER 37 C.F.R. § 41.50(b). THE CLAIMED SUBJECT MATTER The claimed subject matter relates "to a method of removing a stylette from a catheter." Spec. i-f 1. Claim 1 is the only independent claim and recites: 1. A method of removing a hydrophilic coated stylette from an implantable catheter, said method comprising the steps of: handling a catheter that is preloaded with a hydrophilic coated stylette within the catheter; handling the catheter having an inner surface that is coated with a hydrophilic material; placing the hydrophilic coated stylette within a catheter; wetting the hydrophilic coated stylette; and removing the hydrophilic coated stylette from the catheter; wherein the wetting step occurs after the placing the hydrophilic coated stylette within a catheter step. THE REJECTIONS ON APPEAL The Examiner rejected claims 1, 3, 10-12, and 22-23 4 as unpatentable under 35 U.S.C. § 103(a) over Fields (US 5,823,961; iss. Oct. 20, 1998), Calhoun (US 5,606,980; iss. Mar. 4, 1997), and McCorkle (US 4,582,056; iss. Apr. 15, 1986). 4 Although not mentioned in the heading of the Examiner's rejection, the Examiner provides a rationale for rejecting claims 22-23 under that heading. See Final Act. 4. As such, we understand claims 22 and 23 to also be rejected as unpatentable over Fields, Calhoun, and McCorkle. See Br. 3. 2 Appeal2013-005974 Application 11/262,697 The Examiner rejected claims 4--9 as unpatentable under 35 U.S.C. § 103(a) over Fields, Calhoun, McCorkle, and Kaneko (US 2003/0165647 Al; pub. Sept. 4, 2003). The Examiner rejected claims 16-18 as unpatentable under 35 U.S.C. § 103(a) over Fields, Calhoun, McCorkle, Sugita (US 4,969,890; iss. Nov. 13, 1990), 5 and Kaneko. The Examiner rejected claim 13 as unpatentable under 35 U.S.C. § 103(a) over Fields, Calhoun, McCorkle, and Brand (US 2004/0209801 Al; pub. Oct. 21, 2004). The Examiner rejected claim 14 as unpatentable under 35 U.S.C. § 103(a) over Fields, Calhoun, McCorkle, and Roorda (US 6,283,949 Bl; iss. Sept. 4, 2001 ). ANALYSIS Rejection of claims 1, 3, and 10-12 Appellants challenge the Examiner's finding that McCorkle "teaches handling the catheter having an inner surface that is coated with a hydrophilic material." Final Act. 3. Appellants argue that McCorkle [] teaches a first dilating catheter 1 with stylets 9A extending through the entire length of the grasping catheter. (See, column 7, lines 2-5) McCorkle [] also teaches a second dilating catheter 3 that is concentrically disposed about the 5 We note that the Examiner does not identify a citation for "Sugita et al." in the appealed action. In a non-final rejection mailed on January 4, 2008, the Examiner indicates that Sugita et al. is "US Patent 4969890." Non-Final Act. mailed Jan. 4, 2008 at 3. We have assumed that this is the correct citation for the Examiner's reference to Sugita et al. in the appealed action. See Final Act. 6. 3 Appeal2013-005974 Application 11/262,697 Br. 4. grasping catheter 1. (See, column 6, lines 53-56) McCorkle [] also teaches a third ensheathing catheter 5 that is concentrically disposed about the dilating catheter 3. (See, column 6, lines 56- 59) The Examiner has correctly pointed out that McCorkle [] only teaches and suggests that the inner channels of catheters 3 and 5 may, if needed, be coated with a hydrophilic compound. McCorkle [] clearly does not teach or suggest that first grasping catheter 1 be coated with a hydrophilic compound. Of course, first grasping catheter 1 is the only catheter disclosed by McCorkle [] that has stylets 9A extending through the entire length of the catheter. Thus, McCorkle [] teaches away from, not suggesting as the Examiner asserts, [] coating the inner surface of a catheter that has a stylet extending through the entire length of the catheter. "A reference may be said to teach away when a person of ordinary skill, upon reading the reference, would be discouraged from following the path set out in the reference, or would be led in a direction divergent from the path that was taken by the applicant." In re Gurley, 27 F.3d 551, 553 (Fed. Cir. 1994). "The degree of teaching away will of course depend on the particular facts; in general, a reference will teach away if it suggests that the line of development flowing from the reference's disclosure is unlikely to be productive of the result sought by the applicant." Id. "A reference does not teach away, however, if it merely expresses a general preference for an alternative invention but does not 'criticize, discredit, or otherwise discourage' investigation into the invention claimed." DePuy Spine, Inc. v. Medtronic Sofamor Danek, Inc., 567 F.3d 1314, 1327 (Fed. Cir. 2009) (quoting In re Fulton, 391 F.3d 1195, 1201 (Fed Cir. 2004)). 4 Appeal2013-005974 Application 11/262,697 In our view Appellants have not identified a disclosure in McCorkle that criticizes, discredits, or otherwise discourages the coating of an inner surface of a catheter having a stylet running through it. See Br. 4. Mccorkle discloses that "[t]he inner channel surfaces of catheters 3 and 5 are very smooth to allow smooth sliding thereof. If needed, suitable lubricants, such as hydrophilic compounds, are used to coat the surfaces." McCorkle 9:63---66. While Appellants are correct that McCorkle only identifies the two outer catheters as having an inner surface coated with a hydrophilic material, the mere omission of a reference to the innermost catheter does not amount to a teach away under the applicable legal standards. See DePuy, 567 F.3d at 1327. In addition, we also note that, as suggested by the Examiner, the application of the hydrophilic material to the innermost catheter would involve merely the application of the material for the purpose described in the art. Final Act. 3--4. 6 Moreover, the Examiner correctly notes that Appellants' argument relies upon a feature not recited in the claims. See Ans. 9 (noting the claims at issue have "no mention of a stylet extending through the entire length of the catheter"). For the foregoing reasons, we sustain the Examiner's rejection of claim 1. As Appellants do not present separate arguments with respect to 6 We note that the Examiner refers to "Kaneko" here, but we understand that reference to be a typographical error in the context of the rejection. See Final Act. 3--4. 5 Appeal2013-005974 Application 11/262,697 claims 3 and 10-12, we also sustain the Examiner's rejection of those claims. Rejection of claims 4-9 Appellants indicate that each of claims 4--9 "stand or fall with independent claim 1." Br. 5. As such, we sustain the Examiner's rejection of claims 4--9 for the same reasons stated with respect to claim 1. Rejection of claims 16-18 Appellants indicate that each of claims 16-18 "stand or fall with independent claim 1." Br. 5. As such, we sustain the Examiner's rejection of claims 16-18 for the same reasons stated with respect to claim 1. Rejection of claim 13 Appellants indicate that claim 13 "stands or falls with independent claim 1." Br. 5. As such, we sustain the Examiner's rejection of claim 13 for the reasons stated with respect to claim 1. Rejection of claim 14 Appellants indicate that claim 14 "stands or falls with independent claim 1." Br. 6. As such, we sustain the Examiner's rejection of claim 14 for the reasons stated with respect to claim 1. NEW GROUNDS OF REJECTION As we do not have a rationale for the rejection of claim 15, we express no opinion regarding the applicability of the Examiner's rejections to claim 15. However, pursuant to our authority under 37 C.F.R. § 41.50(b), we 6 Appeal2013-005974 Application 11/262,697 reject claim 15 under 35 U.S.C. § 112, fourth paragraph, for failure to further limit the subject matter of the claims from which it depends. The fourth paragraph of 35 U.S.C. § 112 requires that "a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed." Claim 15 depends from claim 12 and recites "wherein the wetting step occurs after the placing step." Claim 12 depends from claim 11 and recites: "wherein the placing the stylette loaded catheter step occurs after the wetting step." Claim 11 depends from claim 1 and recites "the step of placing the stylette loaded catheter at a desired target site within the body." Given the subject matter, we understand the "placing step" recited in claim 15 to be the step of "placing the hydrophilic coated stylette within a catheter" that claim 1 recites. Importantly, claim 1 already includes a limitation on the order in which that step occurs, requiring that "the wetting step occurs after the piacing the hydrophiiic coated styiette within a catheter step." Accordingiy, we determine that claim 15 provides a limitation redundant to a limitation of claim 1 and, therefore, does not further limit the claimed subject matter. For that reason, we reject claim 15. See Pfizer, Inc. v. Ranbaxy Labs. Ltd., 457 F.3d 1284, 1292 (Fed. Cir. 2006). DECISION We affirm the Examiner's rejection of claims 1, 3-14, 16-20, 22, and 23 under 35 U.S.C. § 103(a). We enter NEW GROUNDS OF REJECTION of claim 15 under 35 U.S.C. § 112, fourth paragraph for failure to further limit the subject matter of the claims from which it depends. 7 Appeal2013-005974 Application 11/262,697 Regarding the affirmed rejections, 37 C.F.R. § 41.52(a)(l) provides "Appellant may file a single request for rehearing within two months from the date of the original decision of the Board." In addition to affirming the Examiner's rejection of claims 1, 3-14, 16-20, 22, and 23, this decision contains a new ground of rejection pursuant to 37 C.F.R. § 41.50(b). 37 C.F.R. § 41.50(b) provides "NEW GROUND[S] OF REJECTION pursuant to this paragraph shall not be considered final for judicial review." 37 C.F.R. § 41.50(b) also provides that Appellant, WITHIN TWO MONTHS FROM THE DATE OF THE DECISION, must exercise one of the following two options with respect to the new grounds of rejection to avoid termination of the appeal as to the rejected claims: ( 1) Reopen prosecution. Submit an appropriate amendment of the claims so rejected or new evidence relating to the claims so rejected, or both, and have the matter reconsidered by the Examiner, in which event the proceeding will be remanded to the Examiner . . . . (2) Request rehearing. Request that the proceeding be reheard under § 41.52 by the Board upon the same record .... Should Appellant elect to prosecute further before the Examiner Pur"uant to :n c~ F r< ~ .ct 1 "f11hV l \ 1·n order to p1·ese ...... re tl1e. ri"ght to see1< 0 ,._,•f '---'•-"- •-... ~~ '":!~."" .. \..,~j)\-"-}' ' _l_'i; < l'IL review under 35 tLS.C. §§ 141 or 145 with respect to the affirmed rejections, the effective date of the affirmance is deferred until conclusion of the prosecution before the Exarniner unless, as a mere incident to the limited prosecution, the affin11ed rejections are overcome. If AppeUant elects prosecution before the Examiner and this does not result in aUowance of the application, abandonment or a second appeal, this case should be returned to the Patent Trial and Appeal Board for final action 8 Appeal2013-005974 Application 11/262,697 on the affinned rejections, including any timely request for rehearing thereof No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R § 1.136(a)(l )(iv). AFFIRMED; 37 C.F.R. § 41.50(b) 9 Copy with citationCopy as parenthetical citation